Author:
Sabri Mohammad-Reza,Zolfi-Gol Ali,Ahmadi Alireza,Haghjooy-Javanmard Shaghayegh
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Pediatrics, Perinatology and Child Health
Reference29 articles.
1. Affuso F, Palmieri EA, Di Conza P (2006) Tadalafil improves quality of life and exercise tolerance in idiopathic pulmonary arterial hypertension. Int J Cardiol 108(3):429–431
2. Al-Mousawi NRH, Al Hakim AH (2008) A study of the effect of phosphodiesterase-5-inhibitor on serum lipid profile in the male rats. Kufa Med J 11(1):277–282
3. Arif SA, Poon H (2011) Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension. Clin Ther 33(8):993–1004
4. Bharani A, Patel A, Saraf J et al (2007) Efficacy and safety of PDE-5 inhibitor tadalafil in pulmonary arterial hypertension. Indian Heart J 59(4):323–328
5. Chungsomprasong P, Soongswang J, Nana A et al (2011) Medium and long-term outcomes of Fontan operation. J Med Assoc Thai 94(3):323–330
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献